Mindfulness program for people with Parkinson's and their caregivers
Official title: Enhancing Psychological Wellbeing and the Patient-caregiver Relationship Through Dyadic Mindfulness: A Randomized Controlled Trial in People With Parkinson's Disease and Their Caregivers
Run by The University of Hong Kong · NCT06821230 · Data updated 2026-11-12
This study tests whether a mindfulness program can help people with Parkinson's and their caregivers feel better emotionally and improve their relationship.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 200 (estimated) |
| Sponsor | The University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | February 11, 2025 |
| Main results expected | June 30, 2027 |
| Study ends | June 30, 2027 |
| Registry record updated | June 1, 2026 |
| Trial ID | NCT06821230 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include Chinese individuals aged 50-80 with mild to moderate Parkinson's Disease and their primary caregivers who can communicate in Cantonese.
✕Probably not a fit
Patients who regularly engage in supervised mindfulness practices or have significant cognitive impairments may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial investigates the effects of dyadic mindfulness on both physical and emotional outcomes for individuals with Parkinson's Disease and their caregivers. One hundred patient-caregiver pairs will be randomly assigned to either participate in eight weekly mindfulness sessions or receive usual care. The study will assess various outcomes, including negative emotions, relationship dynamics, mindfulness levels, quality of life, and caregiving burden. Additionally, in-depth interviews will be conducted with a subset of participants to gather qualitative insights on their experiences with the intervention.
Why it matters
Potential benefit: If successful, this program could improve emotional well-being and quality of life for both patients and their caregivers.
How similar studies have gone: While similar mindfulness interventions have shown promise in other populations, this specific dyadic approach in Parkinson's Disease is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria of PwPD: * Chinese patients with idiopathic mild-moderate PD (as indicated by the Hoehn and Yahr Scale stages I-III: those with unilateral/bilateral symptoms, with/without postural instability who are able to walk/stand unassisted) * Aged ≥18 years Inclusion Criteria of caregivers of PwPD: \- Self-identified as the primary caregivers of their patient Either patient or caregiver needs to experience at least mild negative emotions (as indicated by the 21-item Depression, Anxiety and Stress Scale \[DASS21\] score of Depression subscale ≥10, Anxiety subscale ≥8, or Stress subscale ≥15) Both need to be able to communicate in Cantonese and provide written consent. Exclusion Criteria: * Engage in regular supervised mind-body practices such as Tai Chi, yoga, or other forms of mindfulness training (\>2 times per week) * Have a pre-existing acute psychotic disease * Currently participating in any other behavioral or pharmacological trial * Have significant cognitive impairment, as indicated by an Abbreviated Mental Test score≤ 6 * Have other contraindications that may limit their full participation (e.g., severe hearing/vision impairment)
Where it's running
-
School of Nursing, The University of Hong Kong
Hong Kong, Hong Kong Recruiting
Study contacts
- Study coordinator: Jojo Yan Yan Kwok
- Email: jojoyyk@hku.hk
- Phone: 852 39176644
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
iWalk: an eight-week mindfulness walking program to build resilience
This program tests whether an eight-week guided walking meditation can help adults with neurodegenerative conditions (like MS) improve resilience, mood, and self-regulation.
-
Recovering Together After Cardiac Arrest: a mind-body resilience program for survivors and caregivers.
This project will try two brief mind-body programs to help cardiac arrest survivors and their caregivers reduce anxiety, depression, and emotional distress.
-
Registry for Exablate Neuro treatment in Parkinson's Disease
This study is tracking 60 people with advanced Parkinson's Disease to see how well a new treatment using the Exablate Neuro device works for those who haven't had success with medications.
-
Ginger as a Modifier of Ghrelin Levels in Parkinson’s Disease and REM Sleep Behavior Disorder
This study tests whether ginger capsules can raise ghrelin levels in people with Parkinson’s disease, REM sleep behavior disorder, and healthy controls.
-
Blood biomarker cohort for memory disorders in older adults
This observational cohort will collect blood samples and brain imaging data from adults 50+ with memory disorders and a small group of healthy young adults to help find biomarkers.
-
Intraoperative Microelectrode Recordings with MAVEN vs Standard Equipment
This study tests whether MAVEN can match the recording data collected during DBS surgery for movement disorders using standard equipment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.